Company intelligence / Profile preview

DMC Biotechnologies

Boulder, Colorado, United Statesdmcbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company has commercialized its first bio-based chemical intermediate with applications in home care and human nutrition. Its Dynamic Metabolic Control™ platform enables scalable, predictable microbial fermentation to produce sustainable specialty chemicals. L-alanine production claims over 90% CO₂ reduction compared to conventional supply chains. No clinical results as the company does not develop therapeutics.

Therapeutic areas: Other
Modalities: Microbial therapyPrecision fermentationSynthetic biology
Industry: Non-Drug Biotech

Partnerships

None specifically named in public sources; general mention of collaborations with customers/partners on new product development.

Beyond the preview

Go deeper on DMC Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DMC Biotechnologies.

Explore the full profile